“We live in an age where healthcare is increasingly transformed by digital technologies”.
Glen de Vries: CEO, Medidata
None of us has a crystal ball, but when we keep a finger on the pulse of developments in our industry we can gauge which direction it may take tomorrow, and the day after.
This week, over 2,000 life sciences industry leaders gathered in New York to discuss the future of clinical research. The organiser of the event, Medidata, invested the two days with two full decades of expertise as market-leading SaaS providers for clinical trials. The result? Illuminating discussion on topics of vital importance.
Are you following best practice in clinical trials?
Are you exploring new models for clinical development and drug approval?
Are you aware of the opportunities and challenges of virtual clinical trials?
Are you putting data security at the heart of your operation?
Are you taking your service to market with the evidence you need for success?
Above all, are you engaging, retaining and empowering trial patients?
Many of those in attendance are clearly moving in the right direction. Tissue Tech, Arena Pharmaceuticals, PPD, Idera Pharmaceuticals, Bristol-Myers Squibb and ICON Medical Imaging all received awards for excellence in patient engagement, innovation and ground-breaking use of technology to add value to the clinical process. And that key point, how to add value to the clinical process, was returned to time and time again. It’s a question we’re all seeking better and more customer-friendly answers to every day.
Now part of Dassault Systèmes, a 3D design pioneer with a $4 billion turnover, Medidata has even greater scope to support the life sciences sector. Their 2020 conferences in Basel, London, New York, Seoul, Shanghai and Tokyo will offer us innovation and inspiration. We can’t wait.
Conversis: helping you speak to the world
To find out more, contact us using the form below.
Please use the form to get in touch
or alternatively give us a call on: +44 (0)1869 255820